Across TCGA pan-cancer cohorts, HNRNPA1P31 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of HNRNPA1P31’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where HNRNPA1P31 RNA is repressed in tumor relative to normal tissue. In most cancer types HNRNPA1P31 is over-expressed in tumor, although a few such as BRCA and KIRC show the opposite, repressed pattern.

BRCA and KIRC are the cancer types where HNRNPA1P31 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in HNRNPA1P31 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	II,III,IV	−0.007	.044	2	view →
KIRC	Male	All	−0.004	.043	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: HNRNPA1P31 RNA expression & survival · all HNRNPA1P31 data types